Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
902 | 2889 | 42.8 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INVARIANT CHAIN | Author keyword | 130 | 65% | 4% | 125 |
2 | HLA DM | Author keyword | 77 | 75% | 2% | 55 |
3 | ANTIGEN PROCESSING | Author keyword | 28 | 20% | 4% | 127 |
4 | MHC CLASS II | Author keyword | 24 | 16% | 5% | 138 |
5 | HLA DO | Author keyword | 20 | 66% | 1% | 19 |
6 | THIOL REDUCTASE ACTIVITY | Author keyword | 18 | 89% | 0% | 8 |
7 | INTERFERON GAMMA INDUCIBLE LYSOSOMAL THIOL REDUCTASE | Author keyword | 11 | 100% | 0% | 6 |
8 | PEPTIDE BINDING | Author keyword | 10 | 19% | 2% | 45 |
9 | H2 M | Author keyword | 9 | 83% | 0% | 5 |
10 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II | Author keyword | 9 | 21% | 1% | 38 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INVARIANT CHAIN | 130 | 65% | 4% | 125 | Search INVARIANT+CHAIN | Search INVARIANT+CHAIN |
2 | HLA DM | 77 | 75% | 2% | 55 | Search HLA+DM | Search HLA+DM |
3 | ANTIGEN PROCESSING | 28 | 20% | 4% | 127 | Search ANTIGEN+PROCESSING | Search ANTIGEN+PROCESSING |
4 | MHC CLASS II | 24 | 16% | 5% | 138 | Search MHC+CLASS+II | Search MHC+CLASS+II |
5 | HLA DO | 20 | 66% | 1% | 19 | Search HLA+DO | Search HLA+DO |
6 | THIOL REDUCTASE ACTIVITY | 18 | 89% | 0% | 8 | Search THIOL+REDUCTASE+ACTIVITY | Search THIOL+REDUCTASE+ACTIVITY |
7 | INTERFERON GAMMA INDUCIBLE LYSOSOMAL THIOL REDUCTASE | 11 | 100% | 0% | 6 | Search INTERFERON+GAMMA+INDUCIBLE+LYSOSOMAL+THIOL+REDUCTASE | Search INTERFERON+GAMMA+INDUCIBLE+LYSOSOMAL+THIOL+REDUCTASE |
8 | PEPTIDE BINDING | 10 | 19% | 2% | 45 | Search PEPTIDE+BINDING | Search PEPTIDE+BINDING |
9 | H2 M | 9 | 83% | 0% | 5 | Search H2+M | Search H2+M |
10 | MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II | 9 | 21% | 1% | 38 | Search MAJOR+HISTOCOMPATIBILITY+COMPLEX+CLASS+II | Search MAJOR+HISTOCOMPATIBILITY+COMPLEX+CLASS+II |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HLA DR MOLECULES | 351 | 67% | 11% | 313 |
2 | INVARIANT CHAIN PEPTIDES | 164 | 79% | 4% | 104 |
3 | INVARIANT CHAIN | 158 | 35% | 13% | 368 |
4 | DR MOLECULES | 150 | 82% | 3% | 87 |
5 | ANTIGEN PROCESSING MUTANT | 142 | 80% | 3% | 88 |
6 | HLA DM | 104 | 56% | 4% | 128 |
7 | PROCESSING MUTANT | 89 | 92% | 1% | 35 |
8 | ALPHA BETA DIMERS | 86 | 90% | 1% | 37 |
9 | IMMUNOGENIC PEPTIDES | 82 | 48% | 4% | 127 |
10 | HLA DR1 | 71 | 49% | 4% | 107 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pathways of Antigen Processing | 2013 | 98 | 222 | 38% |
Determinants of immunodominance for CD4 T cells | 2015 | 2 | 55 | 82% |
Capture and processing of exogenous antigens for presentation on MHC molecules | 1997 | 560 | 175 | 53% |
Lysosomal cysteine proteases regulate antigen presentation | 2003 | 238 | 115 | 50% |
HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation | 2014 | 5 | 55 | 85% |
MHC-DEPENDENT ANTIGEN-PROCESSING AND PEPTIDE PRESENTATION - PROVIDING LIGANDS FOR T-LYMPHOCYTE ACTIVATION | 1994 | 1083 | 72 | 50% |
Invariant chain structure and MHC class II function | 1996 | 237 | 12 | 100% |
Cell biology of antigen processing in vitro and in vivo | 2005 | 537 | 351 | 27% |
The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules | 2004 | 134 | 125 | 63% |
Proteases involved in MHC class II antigen presentation | 1999 | 145 | 68 | 79% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ZOONOSES ANHUI PROV | 6 | 48% | 0.3% | 10 |
2 | ZUCKERMAN FAMILY CANYON RANCH CRYSTALLOG | 6 | 80% | 0.1% | 4 |
3 | IMMUNOL MOL | 6 | 30% | 0.6% | 16 |
4 | UNIT EXPT ONCOPATHOL | 3 | 100% | 0.1% | 3 |
5 | MED NAT SCI | 2 | 15% | 0.5% | 15 |
6 | INSERM U520 | 2 | 38% | 0.2% | 5 |
7 | AAB | 2 | 44% | 0.1% | 4 |
8 | JIANGSU PROV MOL MED BIOTECHNOL AQUAT | 2 | 67% | 0.1% | 2 |
9 | VU CANC IMMUNOL | 2 | 24% | 0.2% | 6 |
10 | HEMATOLCANC AMSTERDAM | 1 | 100% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000124600 | U396//HU1D10//UNITE 396 |
2 | 0.0000108589 | TAPASIN//TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING//PEPTIDE LOADING COMPLEX |
3 | 0.0000108132 | MURINE MAB//CYTOTOXICITY IMMUNOLOGICAL//DR2 HAPLOTYPES |
4 | 0.0000091748 | IMMUNOINFORMATICS//EPITOPE PREDICTION//COMPUTATIONAL VACCINOLOGY |
5 | 0.0000086560 | CD83//SOLUBLE CD83//MARCH I |
6 | 0.0000081526 | PEPTIDE MHC//PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX//PROT CRYSTALLOG UNIT |
7 | 0.0000078429 | CIITA//BARE LYMPHOCYTE SYNDROME//CLASS II TRANSACTIVATOR |
8 | 0.0000066028 | JOURNAL OF MOLECULAR AND CELLULAR IMMUNOLOGY//TABM//GLYCOSYLATION INHIBITING FACTOR |
9 | 0.0000060389 | PEPTIDE PROT CHEM//PHYSICOCHEM UNIT//QUIM PEPTIDS PROT |
10 | 0.0000051726 | BIFUNCTIONAL PEPTIDE INHIBITOR//TYKESON MS//BATF2 |